Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional expression of a single-chain antibody to ErbB-2 in plants and cell-free systems.
Galeffi P, Lombardi A, Pietraforte I, Novelli F, Di Donato M, Sperandei M, Tornambé A, Fraioli R, Martayan A, Natali PG, Benevolo M, Mottolese M, Ylera F, Cantale C, Giacomini P. Galeffi P, et al. Among authors: mottolese m. J Transl Med. 2006 Sep 29;4:39. doi: 10.1186/1479-5876-4-39. J Transl Med. 2006. PMID: 17010186 Free PMC article.
The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors.
Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, Venturo I, Botti C, Jager E, Santoni A, Natali PG, Nisticò P. Di Modugno F, et al. Among authors: mottolese m. Clin Cancer Res. 2006 Mar 1;12(5):1470-8. doi: 10.1158/1078-0432.CCR-05-2027. Clin Cancer Res. 2006. PMID: 16533770 Free article.
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.
Botti C, Buglioni S, Benevolo M, Giannarelli D, Papaldo P, Cognetti F, Vici P, Di Filippo F, Del Nonno F, Venanzi FM, Natali PG, Mottolese M. Botti C, et al. Among authors: mottolese m. Clin Cancer Res. 2004 Feb 15;10(4):1360-5. doi: 10.1158/1078-0432.ccr-1092-03. Clin Cancer Res. 2004. PMID: 14977837
A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study.
Novelli F, Milella M, Melucci E, Di Benedetto A, Sperduti I, Perrone-Donnorso R, Perracchio L, Venturo I, Nisticò C, Fabi A, Buglioni S, Natali PG, Mottolese M. Novelli F, et al. Among authors: mottolese m. Breast Cancer Res. 2008;10(5):R74. doi: 10.1186/bcr2139. Epub 2008 Sep 4. Breast Cancer Res. 2008. PMID: 18771580 Free PMC article.
Melanoma molecular classes and prognosis in the postgenomic era.
Tremante E, Ginebri A, Lo Monaco E, Frascione P, Di Filippo F, Terrenato I, Benevolo M, Mottolese M, Pescarmona E, Visca P, Natali PG, Giacomini P. Tremante E, et al. Among authors: mottolese m. Lancet Oncol. 2012 May;13(5):e205-11. doi: 10.1016/S1470-2045(12)70003-7. Lancet Oncol. 2012. PMID: 22554548 Review.
243 results